The present invention relates to pharmaceutical composition comprising rimegepant or a pharmaceutically acceptable salts thereof and process for preparation which is simple, economic, cost-effective, and industrially amenable to scale up. Further, the said invention is used for the acute treatment of migraine with or without aura in adults and preventive treatment of episodic migraine in adults